2008
DOI: 10.6026/97320630002325
|View full text |Cite
|
Sign up to set email alerts
|

Virtual screening for novel COX-2 inhibitors using the ZINC database

Abstract: Cyclooxygenase-2 (COX-2) enzyme binds to arachidonic acid and releases metabolites that are used to induce pain and inflammation. COX-2 selective inhibitors such as celecoxib, rofecoxib and valdecoxib are currently used to reduce inflammatory response. However, they lack anti-thrombotic activity and hence lead to cardiovascular and renal liabilities apart from gastrointestinal irritation. Therefore, there is still a need to develop more potent COX-2 inhibitors. In this paper, we report the screening of various… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
22
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 28 publications
(24 citation statements)
references
References 18 publications
1
22
0
Order By: Relevance
“…The availability of the directory of useful decoys (DUD) which has provided libraries to benchmark the SBVSs for both COX-1 and COX-2 are very beneficial to retrospectively validated the developed SBVS protocols [7]. Some efforts to develop SBVS tools to identify COX-2 inhibitors have been performed and resulted in SBVS protocols with good quality [7][8][9][10]. The availability of some new COX-2 crystal structures has also opened more opportunities to increase the quality of the available SBVS protocols in identifying COX-2 inhibitors [11].…”
Section: Introductionmentioning
confidence: 99%
“…The availability of the directory of useful decoys (DUD) which has provided libraries to benchmark the SBVSs for both COX-1 and COX-2 are very beneficial to retrospectively validated the developed SBVS protocols [7]. Some efforts to develop SBVS tools to identify COX-2 inhibitors have been performed and resulted in SBVS protocols with good quality [7][8][9][10]. The availability of some new COX-2 crystal structures has also opened more opportunities to increase the quality of the available SBVS protocols in identifying COX-2 inhibitors [11].…”
Section: Introductionmentioning
confidence: 99%
“…Computational chemistry for in silico screening is now an established platform for identification of lead compounds in the drug discovery process (Yang et al, 2007;Sudha et al, 2008;Chang et al, 2010;Wassman et al, 2013). This approach utilizes the prediction of binding poses and affinities of each docked compound to the crystal structure of a target protein.…”
Section: Introductionmentioning
confidence: 99%
“…COX-2 is an oxidoreductase enzyme playing a role in prostaglandin biosynthesis and inflammatory responses. The COX-2 enzyme binds to arachidonic acid which causes pain and inflammation (Sudha et al, 2008). COX-2 is one of the well-known targets for the antiinflammatory therapy.…”
Section: Introductionmentioning
confidence: 99%